Request To Download Free Sample of This Strategic Report @- The Global Xerostomia Therapeutics Market is poised for significant growth, with an anticipated reach of over USD 822.14 million by 2026, ...
Xerostomia is most commonly caused by the use of xerogenic medications. [7,8] More than 400 drugs, some in common use, can cause oral dryness and induce salivary gland hypofunction. [9] Xerogenic ...